The National Institute of Neurological Disorders and Stroke and Department of Defense Sport-Related Concussion Common Data Elements Version 1.0 Recommendations by Broglio, S.P. et al.
This is a repository copy of The National Institute of Neurological Disorders and Stroke 
and Department of Defense Sport-Related Concussion Common Data Elements Version 
1.0 Recommendations.
White Rose Research Online URL for this paper:
http://eprints.whiterose.ac.uk/131196/
Version: Accepted Version
Article:
Broglio, S.P., Kontos, A.P., Levin, H. et al. (27 more authors) (2018) The National Institute 
of Neurological Disorders and Stroke and Department of Defense Sport-Related 
Concussion Common Data Elements Version 1.0 Recommendations. Journal of 
Neurotrauma. ISSN 0897-7151 
https://doi.org/10.1089/neu.2018.5643
eprints@whiterose.ac.uk
https://eprints.whiterose.ac.uk/
Reuse 
Items deposited in White Rose Research Online are protected by copyright, with all rights reserved unless 
indicated otherwise. They may be downloaded and/or printed for private study, or other acts as permitted by 
national copyright laws. The publisher or other rights holders may allow further reproduction and re-use of 
the full text version. This is indicated by the licence information on the White Rose Research Online record 
for the item. 
Takedown 
If you consider content in White Rose Research Online to be in breach of UK law, please notify us by 
emailing eprints@whiterose.ac.uk including the URL of the record and the reason for the withdrawal request. 
  
The National Institute of Neurological Disorders and Stroke and Department of Defense Sport-
Related Concussion Common Data Elements Version 1.0 Recommendations 
Steven P. Broglio, PhD, ATC (Corresponding author) 
NeuroTrauma Research Laboratory 
University of Michigan 
401 Washtenaw Ave 
Ann Arbor, MI  48109 
734.764.9669 (o) 
734.936.1925 (f) 
broglio@umich.edu 
 
Anthony P. Kontos, PhD 
UPMC Rooney Sports Complex 
University of Pittsburgh 
3200 South Water St 
Pittsburgh, PA 15203 
412.432.3725 (o) 
412.432.3644 (f) 
akontos@pitt.edu 
 
Harvey Levin, PhD 
Baylor College of Medicine 
Michael E. DeBakey VA Medical Center 
Neurosensory Center Room: NB136, Mail Stop: BCM637 
Houston, Texas 77030 
713.798.7566 (o) 
hlevin@bcm.edu 
 
Kathryn Schneider, PT, PhD 
Sport Injury Prevention Research Centre 
Faculty of Kinesiology 
Alberta Children’s Hospital Research Institute 
Hotchkiss Brain Institute 
University of Calgary 
Calgary, Alberta, Canada 
403.210.8951(o) 
kjschnei@ucalgary.ca 
 
Elisabeth A. Wilde, PhD 
University of Utah School of Medicine  
Baylor College of Medicine 
Michael E. DeBakey VA Medical Center 
Departments of Physical Medicine and Rehabilitation, Neurology and Radiology 
One Baylor Plaza, BCM637 
  
Houston, TX 77030 
713.798.7331 (o) 
ewilde@bcm.edu 
 
Robert C. Cantu, MD 
Concussion Center at Emerson Hospital 
131 ORNAC, Suite 820 
Concord, MA 01742 
978.369.1386 (o) 
978.287.0047 (f) 
 rcantu@emersonhosp.org 
 
Nina Feddermann-Demont, MD 
University Hospital Zurich 
University of Zurich 
Swiss Concussion Center 
Schulthess Klinik 
Lengghalde 2 
CH-8008 Zürich 
+41 44 385 72 00 (o) 
+41 44 385 77 92 (f) 
nina.feddermann@swissconcussion.com 
 
Gordon W. Fuller, MPH, PhD 
Centre for Urgent and Emergency Care Research 
School of Health and Related Research (ScHARR) 
University of Sheffield 
Regent Court 
30 Regent Street 
Sheffield 
S1 4DA 
0114 222 0751 (o) 
0114 222 0749 (f) 
g.fuller@sheffield.ac.uk 
 
Isabelle Gagnon, PT, PhD 
Montreal Children's Hospital, MUHC 
5252 Boul de Maisonneuve Ouest, Office 3F-45 
Montréal, Québec, H4A 3S5, Canada 
514.412.4400 x23896 (o) 
514.412.4398 (f) 
Isabelle.gagnon8@mcgill.ca 
 
Gerard A. Gioia, PhD 
Children’s National Health System 
  
15245 Shady Grove Road, Suite 350 
Rockville, Maryland 20850 
301.765.5430 (o) 
GGioia@childrensnational.org 
 
Christopher Giza, MD 
UCLA Brain Injury Research Center 
Steve Tisch BrainSPORT Program 
University of California – Los Angeles 
300 Stein Plaza, 531 Wasserman 
Los Angeles, CA 90095 
310.794.4070 (o) 
CGiza@mednet.ucla.edu 
 
Grace S. Griesbach, PhD 
Centre for Neuro Skills 
16542 Ventura Blvd. Ste. 500  
Encino CA 91436  
818. 815.3203 (o) 
818.783.8412 (f) 
 ggriesbach@neuroskills.com 
 
John J. Leddy, MD 
SUNY Jacobs School of Medicine and Biomedical Sciences 
University at Buffalo 
160 Farber Hall- SUNY 
Buffalo, NY 14214 
716.829.5501(o) 
leddy@buffalo.edu 
 
Michael L. Lipton, MD, PhD 
Albert Einstein College of Medicine and Montefiore Medical Center 
1300 Morris Park Ave 
Bronx, NY 10461 
718.430.3390 (o) 
718.430.2185 (f) 
 michael.lipton@einstein.yu.edu 
 
Andrew R. Mayer, PhD 
The Mind Research Network 
University of New Mexico 
1101 Yale Blvd. NE 
 Albuquerque, NM 87106  
505.272.0769 (o) 
505.272.8002 (f) 
  
amayer@mrn.org 
 
Thomas W. McAllister, MD 
Indiana University School of Medicine 
IU Health Neuroscience Center 
355 W. 16th Street, Suite 4800 
GH, Room 4250 
Indianapolis, IN 46202-7176 
317.963.7288(o) 
317.963.7313 (f) 
twmcalli@iupui.edu 
 
Michael McCrea, PhD 
Medical College of Wisconsin 
8701 Watertown Plank Road 
Milwaukee, WI 53226 
414.955.7302 (o) 
414.955.0115 (f) 
mmccrea@mcw.edu 
 
Lara McKenzie, PhD, MA 
The Research Institute at Nationwide Children's Hospital 
700 Children's Drive 
Columbus, OH 43205 
614.355.5855 (o) 
614.355.5897 (f) 
Lara.McKenzie@nationwidechildrens.org 
 
Margot Putukian, MD 
Princeton University 
Washington Road 
 Princeton, NJ 08544 
609.258.8471 (o) 
 609.258.1355 (f) 
putukian@Princeton.edu 
 
Stefano Signoretti, MD, PhD 
Azienda Ospedaliera (A.O.) 
San Camillo-Forlanini Hospital 
Circonvallazione Gianicolense 
87 - 00152 Roma 
+39 06 58704354 (o) 
+39 06 58704207 (f) 
stefano.signoretti2@gmail.com 
 
Stacy J. Suskauer, MD 
  
Kennedy Krieger Institute and Departments of Physical Medicine  
& Rehabilitation and Pediatrics 
Johns Hopkins University School of Medicine 
707 North Broadway 
Baltimore, MD 21205 
443.923.9440 (o) 
443.923.9445 (f) 
suskauer@kennedykrieger.org 
 
Robert Tamburro, MD, MSc 
Johns Hopkins University School of Medicine 
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) 
6710B Rockledge Drive, Room 2331-C 
Bethesda, Maryland, 20817 
301.480.2619 (o) 
301.496.0962 (f) 
robert.tamburro@nih.gov 
 
Michael Turner, MD 
The International Concussion and Head Injury Research Foundation  
The Institute of Sport, Exercise and Health (ISEH) 
170 Tottenham Court Road 
London W1T 7HA, United Kingdom 
+44.203.447.2800 (o) 
+44.208.711.3512 (f) 
michael@ichirf.org 
 
Keith O. Yeates, PhD 
University of Calgary 
2500 University Dr. NW, AD254 
Calgary, AB T2N 1N4, Canada 
403.220.2928 (o) 
403.282.8249 (f) 
kyeates@ucalgary.ca 
 
Roger Zemek, MD 
Children’s Hospital of Eastern Ontario Research Institute 
401 Smyth Road 
Ottawa, ON K1H 8L1, Canada 
613.737.7600 x3931 (o) 
613.738.4250 (f) 
rzemek@cheo.on.ca 
 
Sherita Ala’i, MS 
The Emmes Corporation  
  
401 N. Washington Street, Suite 700 
Rockville, MD 20850 
301.251.1161 (o) 
301.251.1355 (f) 
salai@emmes.com 
 
Joy Esterlitz, MS 
The Emmes Corporation  
401 N. Washington Street, Suite 700 
Rockville, MD 20850 
301.251.1161 (o) 
301.251.1355 (f) 
jesterlitz@emmes.com 
 
Katelyn Gay, BS 
The Emmes Corporation  
401 N. Washington Street, Suite 700 
Rockville, MD 20850 
301.251.1161 (o) 
301.251.1355 (f) 
kgay@emmes.com 
 
Patrick S.F. Bellgowan, PhD 
National Institute of Neurological Disorders and Stroke (NINDS) 
NINDS - Neuroscience Center 
Division of Extramural Activities 
6001 Executive Boulevard Suite 3309 
Bethesda, MD 20892 
301.496.1447 (0) 
patrick.frostbellgowan@nih.gov 
 
Kristen Joseph, MA 
The Emmes Corporation  
401 N. Washington Street, Suite 700 
Rockville, MD 20850 
301.251.1161 (o) 
301.251.1355 (f) 
kjoseph@emmes.com 
 
On behalf of the Sport-Related Concussion CDE Working Group 
 
Word count: 3,321 
Abstract: 289 
Manuscript: 3,032 
Figures and table: 2 
  
ABSTRACT 
Through a partnership with the National Institute of Neurological Disorders and Stroke 
(NINDS), National Institutes of Health (NIH), and Department of Defense (DoD), the 
development of Sport-Related Concussion (SRC) Common Data Elements (CDEs) was initiated. 
The aim of this collaboration was to increase the efficiency and effectiveness of clinical research 
studies and clinical treatment outcomes, increase data quality, facilitate data sharing across 
studies, reduce study start-up time, more effectively aggregate information into metadata results, 
and educate new clinical investigators. The SRC CDE Working Group consisted of 32 
worldwide experts in concussion from varied fields of related expertise, divided into three 
Subgroups: Acute (<72 hours post-concussion), Subacute (3 days-3 months post-concussion) and 
Persistent/Chronic (>3 months post-concussion). To develop CDEs, the Subgroups reviewed 
various domains, and then selected from, refined, and added to existing CDEs, case report forms 
and field-tested data elements from national registries and funded research studies. 
Recommendations were posted to the NINDS CDE Website for Public Review from February 
2017 to April 2017. Following an internal Working Group review of recommendations, along 
with consideration of comments received from the Public Review period, the first iteration 
(Version 1.0) of the NINDS SRC CDEs was completed in June 2017. The recommendations 
include Core and Supplemental – Highly Recommended CDEs for cognitive data elements and 
symptom checklists, as well as other outcomes and endpoints (e.g., vestibular, oculomotor, 
balance, anxiety, depression) and sample case report forms (e.g., injury reporting, demographics, 
concussion history) for domains typically included in clinical research studies.  The NINDS SRC 
CDEs and supporting documents are publicly available on the NINDS CDE website 
https://www.commondataelements.ninds.nih.gov/. Widespread use of CDEs by researchers and 
  
clinicians will facilitate consistent SRC clinical research and trial design, data sharing, and 
metadata retrospective analysis.  
Keywords: Traumatic Brain Injury; Assessment tools; other 
  
INTRODUCTION 
 
In 2006, the National Institute of Neurological Disorders and Stroke (NINDS) initiated 
the development of Common Data Elements (CDEs) to assist NINDS-funded investigators 
studying various neurological diseases in collecting clinical and research data in a standard and 
consistent format. The overall goals of the NINDS CDE Project are to: 1) disseminate standards 
for the collection of data from participants enrolled in studies of neurological diseases, 2) create 
easily accessible tools for investigators to collect study data, 3) encourage focused and simplified 
data collection to reduce burden on investigators and practice-based clinicians to facilitate their 
participation in clinical research, and 4) improve data quality while controlling cost by providing 
uniform data descriptions and tools across NINDS-funded clinical studies.1 The traumatic brain 
injury (TBI) CDE initiative began in 2008 with support from the NINDS in cooperation with 
representatives from other federal agencies funding TBI-related research (i.e., Department of 
Veterans Affairs [VA], the National Institute of Disability, Independent Living, and 
Rehabilitation Research [NIDILRR] of the Department of Education, the Defense Centers of 
Excellence [DCoE] for Psychological Health and Traumatic Brain Injury of the Department of 
Defense [DoD], and the Defense and Veterans Brain Injury Center [DVBIC] of the DoD). Expert 
panel members addressed four types of data collection: 1) acute injury and demographic data, 2) 
biospecimens, 3) neuroimaging, and 4) outcome measurements. The original (Version 1.0) 
recommendations for each of these areas in TBI and psychological health were published in 
November 2010 in a special issue devoted to the TBI CDEs,2-10 and additional recommendations 
for pediatric populations were published in 2012.11-14  
In response to user experience, and acknowledging the limitations of the initial version of 
the TBI CDEs, the TBI CDE workgroups were restructured to better address more circumscribed 
  
ranges of acuity and severity and additional research foci. New workgroups were established to 
tailor the original recommendations for 1) epidemiological studies, 2) acute hospitalization 
studies, 3) rehabilitation studies, and 4) mild TBI/concussion. Recommendations from these 
efforts were published in Version 2.0 of the TBI CDEs in 201315 and are publicly available.16 
Although many TBI CDE outcome data elements and variables from Version 1.0 were retained 
in Version 2.0, additional measures were added to specifically address common research 
questions specific to mild TBI and concussion. Additionally, a preliminary effort was made to 
incorporate a limited set of elements relevant to studies of sport-related concussion (SRC) and 
mild TBI within military populations. However, despite these adjustments, the detailed and 
systematic consideration of CDEs for SRC per se was a recognized weakness, particularly 
considering the large number of funding proposals, published manuscripts, and active projects in 
this particular area of TBI research. 
SRC represents a subset of mild TBI, which occurs during athletic competition or 
practice.17 These injuries are often observed and evaluated at the point of injury by sports 
medicine professionals (e.g., athletic trainers, physiotherapists, and physicians), but may not be 
evaluated until later post-injury time points by primary care, neurological, neuropsychological, 
neurosurgical, pediatric, emergency department or specialty clinic healthcare professionals. 
SRCs may be complicated by a number of modifying or risk factors including prior concussion 
as reflected by its high incidence among athletes relative to the general population.17 Research 
involving SRC includes initial identification of acute injury, injury biomechanics, assessment of 
involved domains across all phases of injury (i.e., acute, subacute, chronic), recovery monitoring, 
and clinical trials of the effectiveness of interventions to reduce morbidity and recovery time. 
Research participants in SRC studies typically range in age from childhood through at least 
  
middle adulthood, but the residual effects of SRC in children and older individuals are also of 
interest. With expanding research activity in each of these areas of SRC and populations, NINDS 
recognized the need to develop appropriate CDEs to harmonize data collection across studies, 
with a particular emphasis on federally-funded projects, to enable comparison of results across 
studies from this burgeoning area of investigation. This paper describes the process wherein 
NINDS recruited worldwide experts representing diverse research and clinical backgrounds in 
SRC to serve on committees that evaluated and recommended candidate CDEs for specific post-
injury time points.  
 
METHODS 
The multi-disciplinary panel used to identify SRC CDEs was created using current and 
former SRC grantees from domestic and international governmental funding agencies, 
participant lists from international SRC guideline development, and lead personnel in SRC 
related organizations. A principal consideration was to include a diverse knowledge across 
academic backgrounds, sport, participant age, clinical expertise, and research methodology. 
During the planning of this project, two working groups were proposed with a recommended 
minimum of 8 persons per working group. We assumed an approximate 50% acceptance rate to 
participate and developed an initial list of 35 invitees, including experts in both adult and 
pediatric SRC, from diverse training and expertise backgrounds that included athletic training, 
kinesiology, neurosurgery, neurology, neuroradiology, physical therapy, physical medicine and 
rehabilitation, psychiatry, and general pediatrics.  
To establish the SRC CDEs, the injury spectrum was ultimately divided into three 
subgroups based on injury chronicity: 1) Acute, 2) Subacute, and 3) Persistent/ Chronic.  Acute 
  
SRC CDEs were identified based on typical clinical or research evaluations that would occur 
from the time of injury until 72 hours post-injury. This timeframe was implemented to include 
delayed reporting and at least one clinic exam in most instances. Subacute SRC CDEs were 
identified as assessments that would occur between 72 hours and 3 months post-injury. This time 
period was used to focus more on clinical and laboratory measures typically used following an 
initial acute or on-field evaluation. Persistent/ Chronic CDEs focused on common injury-related 
variables and data elements of interest that would occur during a post-injury interval of three or 
more months. This timeframe specifically incorporated CDEs to address longer-term sequelae 
and accommodate studies with a developmental focus or studies that addressed potential long-
term SRC-related neurodegenerative change. 
The NINDS Program Directors selected chairpersons for each Working Group to lead 
discussions and coordinate specific tasks. The Working Group included members with expertise 
in both adult and pediatric populations. Members of each Working Group began by evaluating 
existing NINDS mild TBI/concussion CDEs. The initial screening was done independently by 
the group members prior to organized conference calls, with call time dedicated to achieving 
consensus on specific items where a priori consensus did not exist. Following the review of the 
previously available CDEs, each member of the Working Group was asked for suggestions 
related to other tools/instruments based on his or her knowledge of the SRC literature and 
professional experience. Deliberations of each panel led to inclusion/exclusion and subsequent 
ranking of the candidate data elements for a specific context of use (e.g., to assess cognition 
during the first 72 hours post-concussion in adolescents) based on the evidence for the measure’s 
utility in SRC populations, accessibility, psychometric characteristics (e.g., validity, reliability), 
  
ease of administration, and burden on the injured athlete. The following sections report the 
recommendations of the three Working Groups.  
Following the identification of all potential CDEs, the individual data elements were 
categorized into one of four categories of priority based on their evidenced-based support in the 
SRC literature and psychometric properties, a stratification consistent with the convention of 
other CDEs: Core, Supplemental – Highly Recommended, Supplemental, or Exploratory.18 A 
description of each category is provided in Table 1.  
Working Group members attempted to streamline the recommended data elements to 
those with the broadest applicability and greatest utility in the SRC field per se. In other 
instances, new domains and data elements were suggested, reviewed and recommended to 
capture additional areas of interest in this field, based on Working Group members’ professional 
expertise and knowledge of the SRC literature. The Working Groups’ recommendations reflected 
the position that when there was no recommended measure to address a given domain or 
construct, investigators would be encouraged to select additional data elements that best suited 
the research focus of their studies. 
Following the process outlined above, all identified CDEs were made available for public 
viewing and comment for a three-month period between February and April 2017. The public 
was informed via email to investigators and listservs as well as through national meetings where 
the public review period was advertised to clinical research investigators. The public review 
packet consisted of all the materials that were to be posted on the website, including summary 
tables of recommendations, template case report forms and recommended instruments for 
measuring various outcomes and endpoints. Following the public review period, the SRC 
Working Groups reviewed a compilation of suggestions and edits received from outside 
  
reviewers which consisted of clinical and research experts in the field, patient advocates, and 
other stakeholders. These revisions were addressed with responses sent to public reviewers as 
necessary. Further review and revision of CDEs is encouraged on the NINDS CDE website via 
the feedback links on each page. On June 1, 2017, Version 1.0 of the SRC CDE 
recommendations were posted on the NINDS CDE website on June 1, 2017.19  
 
RESULTS 
Of the initial 35 invitees, 32 to participate, providing a diverse representation of 
knowledge and skills across disciplines and research methodology, including both pediatrics and 
adults.  CDEs specific to each of the three post-injury temporal periods were identified following 
the process outlined above. Table 2 summarizes the Core (i.e., may be required) and 
Supplemental – Highly Recommended (i.e., strongly recommended) symptom and clinical 
outcome data elements. These data elements cover domains including neuromotor functioning, 
neuropsychological functioning, and post concussive/TBI-related symptoms. However, 
depending on the focus of the study, additional Supplemental and Exploratory outcome data 
elements may be selected (please refer to the comprehensive table of CDEs for SRC on the 
NINDS website for measures in the Supplemental and Exploratory categories). Additional 
information on individual data elements within each category can be located on the NINDS CDE 
website. Furthermore, depending on the post-injury time point of interest, the data elements 
below may also be recommended as Supplemental or Exploratory. 
Cognitive assessments (i.e., Automated Neuropsychological Assessment Metrics 
[ANAM], Axon Sports Computerized Cognitive Assessment Tool [CCAT], CNS Vital Signs, or 
  
Immediate Post-Concussion Assessment and Cognitive Testing [ImPACT] in Table 2) were 
identified as a Core CDE by all sub-groups, but researchers should be cognizant that only one 
cognitive assessment is needed as a Core CDE in study implementation. In addition, we note that 
despite the standardization and primary use of computerized tools in the acute and subacute post-
injury intervals, there may be situations where the administration of these measures is also useful 
in the chronic post-injury interval. An example may include the use of these measures in 
longitudinal assessment (for direct comparison with this data collected at an earlier time 
interval). However, we acknowledge that there may also be circumstances or research designs 
where these measures are not as useful in the chronic interval. 
Similar to the cognitive assessments, only one Core Post-concussive/mild TBI Related 
Symptoms assessment need be implemented, some of which are bundled with the cognitive 
assessments, but may be administered independently. For example, the Post-Concussion 
Symptom Scale (PCSS) is included with the ImPACT tool, but it can also be administered 
separately as a paper and pencil test.     
Note that the SRC Core and Supplemental – Highly Recommended CDEs generally have 
broad applicability across different post-injury intervals. However, specific elements were 
classified differently (i.e., Supplemental – Highly recommended, Supplemental, and 
Exploratory) by the three Working Groups, as the target constructs were more, or less applicable 
to particular post-injury intervals. For example, data elements assessing concussion-related 
disorientation were deemed more important in the acute phase as opposed to the chronic post-
injury interval. Additionally, there were elements whose applicability depended upon the age 
range of the study population (e.g., younger children versus collegiate athletes versus older 
retired professional athletes), the study setting (e.g., brief acute sideline assessment versus 
  
clinical or laboratory assessment that allows access to specialized equipment, longer evaluation, 
etc.) and the research question (e.g., effects of acute concussion versus long-term effects of 
repetitive injury). The Working Group members also acknowledged there may be preferred data 
elements for situations requiring longitudinal (repeated) evaluation versus a single assessment 
due to the existence of alternate forms to mitigate practice effects. Finally, there may be injury-
related data elements that are more, or less applicable in different types of sport and populations. 
In addition to outcome and objective CDEs, there is a set of Core demographic variables 
which should be collected in all neurological disease research studies to characterize the sample 
from which data are collected. These data are obtained by self-report, from a parent or legal 
guardian when minors are enrolled, or from another reliable source. Case report forms (CRFs) 
are available on the website1 for these and other Supplemental (not Core or Supplemental – 
Highly Recommended) SRC-specific demographic, socioeconomic status, general health history 
(including personal medical history, participant and family psychological history, concussion 
history, migraine history and substance use), injury report, return to sports, clinical examination, 
vital signs, medications, imaging, and treatment variables.   
Lastly, the SRC injury assessment data elements include CRF templates for reporting 
injury (see Injury Report CRF), and medical intervention (see Treatments Interventions NCAA 
Concussion Treatment CRF), prior concussion history (see Concussion History CRF including 
loss of consciousness/duration of loss of consciousness, post-traumatic amnesia, post-concussive 
symptoms and mechanism of injury variables), and return to sports elements such as 
rehabilitation status (see Return to Play CRF). Other specific CRFs for associated conditions of 
interest in SRC, such as migraine history, are also available (see Migraine History and Personal 
  
Medical History CRFs), as well as CRFs to record the provision of treatments common in SRC 
(see Injury Report CRF; e.g., cognitive rest, physical exertion therapy, vestibular/oculomotor 
therapies, vision therapies, medications). In addition, data elements for imaging variables were 
included with assessments of cavum septum pellucidum and white matter hyperintensities in 
addition to other CDEs used in more severe TBI (see Imaging CRF). Although these features 
may be considered as benign and/or incidental, recent interest in these findings prompted 
inclusion to more accurately determine their base rate and relation to outcome in athletes with 
SRC. These template CRFs can serve as the foundation for documenting participant 
characteristics, participant and family history, injury reports, assessments and examinations, and 
interventions.  
 
DISCUSSION 
In view of the high incidence of SRC reported in the literature and the expanding 
research in this type of TBI, it is timely to implement CDEs into clinical research, similar to 
other types of TBI.20-22 This manuscript outlines the NINDS SRC CDEs for use in observational 
research and clinical trials. Specifically, the paper highlights Core and Supplemental – Highly 
Recommended CDEs across three distinct SRC temporal categories that represent domains 
including cognitive function, post-concussive symptoms, neuromotor function, mood/anxiety, 
vestibular and oculo motor function, and quality of life. These SRC CDEs and previous CDEs 
developed by NINDS represent the standard by which outcome data are to be collected to ensure 
data quality using consistent definitions and uniform capture methodologies. CDEs are designed 
to facilitate comparison of results across studies by harmonizing SRC characterization, 
  
demographic characteristics, and clinical outcome data elements. While not mandatory in all 
instances, use of CDEs is strongly encouraged to merge data from multiple sources and many 
CDEs are currently being used by the Federal Interagency Traumatic Brain Injury Research 
(FITBIR) informatics system.23 The FITBIR platform allows data from multiple studies to be 
integrated and re-analyzed with greater statistical power than any single study can provide.  
Investigators should be mindful of the CDEs identified herein with similarities to other 
injuries along the TBI spectrum. Many of the SRC CDEs were derived from existing TBI CDEs, 
while others were unique and specific to SRC research during specific data collection time points 
(i.e., Acute, Subacute, Persistent/Chronic). At a minimum, the Core SRC variables should be 
collected whenever feasible, with strong consideration of the Supplemental – Highly 
Recommended CDEs. The Supplemental – Highly Recommended CDEs, however, in addition to 
those identified as Supplemental and Exploratory, should not be used in isolation of other study-
specific variables (i.e., variables not currently identified as a CDE) developed by the 
investigative team. Indeed, study specific variables are necessary to facilitate the cutting-edge 
research necessary to keep the field moving forward and develop new CDEs that reflect our 
evolving knowledge of SRC. To that end, the CDEs listed here represent the first iteration of data 
elements to be used in SRC research. As studies are completed and the science evolves, it is 
projected that CDEs will change accordingly. Experience, increased evidence, and new data 
elements will inform the revision process, but the current version offers standardization across 
investigations, as opposed to the current colloquial nature of data collection.   
Limitations and Remaining Gaps 
  
Several important issues confronted the Working Groups during their review and 
selection of CDEs for SRC. First, categorization by the Working Group of candidate data 
elements into the Core, Supplemental – Highly Recommended, Supplemental, and Exploratory 
categories of outcome data elements was challenging due to the paucity of literature examining 
the psychometric properties of many of the data elements when used to specifically assess SRC. 
Second, members of the Working Group acknowledged that some of the CDEs may require 
specialized equipment or expertise and may not be feasible to implement in certain settings.17 In 
addition, the temporal classifications of Acute, Subacute, and Persistent/Chronic may not reflect 
all age categories.24 Third, although it was acknowledged that military personnel may sustain 
SRC as part of their training or during, before, or after deployment, Working Group members 
elected to exclude data elements that were specific to combat or blast exposure, or concussions 
sustained as part of military training. We suggest that investigators studying military populations 
consider additional data elements appropriate for military personnel listed in the V2.0 CDEs for 
mild TBI/concussion. Finally, it is important to acknowledge the unmet needs/unanswered 
questions identified via the SRC CDE process. Some of the current CDEs have unknown 
psychometrics and sensitivity to change in SRC; and CDEs surrounding head impact 
biomechanics, fluid biomarkers, and imaging warrant further attention for application in future 
research on SRC. In addition, while the CDEs identified here will apply to the majority of sports, 
there may be instances to which they do not apply.  
To address some of these concerns and the ever-evolving nature of the field, an annual 
Oversight Committee will be formed starting in 2018 to review all recommendations for updates. 
This Oversight Committee will be comprised of 8-10 members selected from the current SRC 
Working Group in addition to outside members that will provide a fresh perspective on the 
  
current CDE recommendations. New members may include athletes, patient advocates, industry, 
and additional SRC experts. The Oversight Committee recommendations may be posted for 
public comment before being finalized and posted to the NINDS CDE website.   
CONCLUSIONS 
 
The NINDS SRC CDE Working Group’s recommendations are the initial step in an 
evolving process. In this first iteration, we provide CDEs for SRC that can help bridge current 
inconsistencies in research and facilitate data sharing, and combined dataset analyses. However, 
we recognize the need for further investigation of the psychometric properties of several CDEs, 
especially in areas in which there are limited published data such as in children and youth sports, 
older adult athletes, and SRC in female athletes. Long term or longitudinal data on the late 
chronic effects of SRC are also presently limited, thus future updates of the CDEs will be 
necessary as additional data is collected. Future CDEs may also address outcome data elements 
for specific interventions, which involve new technologies or novel application of existing 
technologies. Despite these limitations, application of the Working Group’s recommendations 
will facilitate harmonization of methods across federal and non-federally funded studies, enable 
comparison of their results and secondary analysis of their data when accessed by other 
investigators through FITBIR.   
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